Market positioning Target biopharma and biomedical instrumentation firms focusing on precision analytical equipment and biocompatible systems, highlighting VICI’s expertise in valves, fittings, actuators, and integration for diagnostic and cancer/pulmonary therapy applications to expand strategic partnerships.

Growth opportunities Leverage recent industry shifts toward therapeutics by positioning VICI as a supplier for enhanced analytical workflows and scalable components in clinical labs and research settings, aligning with potential customers expanding into therapeutic area development.

Tech enablement Emphasize versatile product suite and interoperability with common lab tech stacks (cloud services, digital interfaces, automation hardware) to resonate with labs investing in digitalization and automated analytical pipelines.

Operational scale Highlight mid-market footprint (employees 51-200) as a nimble partner capable of customized solutions, fast iteration, and responsive support for mid-sized research labs and contract manufacturing organizations seeking reliable valve and instrumentation supply.

Value proposition Promote reliability, biocompatibility, and integration of Valco products for high-purity analytical and biomedical workflows, underscoring long-term lifetime value and potential for bundled maintenance packages and service contracts.